Home / Clinics Supported / Joint & Musculoskeletal
Open a Joint & Musculoskeletal Clinic
Where Aging Joints Meet Athletic Recovery.
Two large patient populations. One underserved clinic model. The chronic joint pain patient and the active individual seeking faster recovery are both searching, and in most U.S. markets, no dedicated regenerative clinic is answering them.
Book a Strategy CallTwo Patient Populations.
One High-Demand Clinic Model.
The first patient is 55, has chronic knee pain, and has been told their only option is a cortisone shot or eventual surgery. They are actively searching for a non-surgical alternative, platelet-rich plasma therapy, shockwave therapy, and regenerative protocols, and finding very few local clinics.
The second patient is 38, trains regularly, and wants faster recovery from a shoulder injury. They know about PRP and have read about peptide protocols, and they are willing to pay for results that get them back faster than physical therapy alone.
Both patients are searching in your market right now. A single well-positioned joint and musculoskeletal clinic serves both.
The patient who avoids surgery because of your clinic doesn't forget it. That outcome, and that gratitude, is the foundation of the referral engine that makes these clinics grow.
Age 45-70
Knee, hip, shoulder pain
Avoiding surgery
Referred by primary care
Age 25-50
Sports injuries, tendon issues
Faster recovery goal
Finds via search & community
Still Underserved in Most Markets,
First-Mover Advantage Is Real
Regenerative joint clinics remain significantly less competitive than medical weight loss or med spa in most U.S. markets. In most mid-sized markets, no dedicated clinic offers PRP, shockwave, and regenerative recovery under one roof.
Concentrated growth factors from the patient's own blood, joint injections, tendon repair, and tissue regeneration. The category anchor service.
Extracorporeal shockwave therapy to stimulate healing in the joint, tendon, or ligament, supporting tissue repair and pain reduction. A well-established, non-invasive modality. Premium positioning, strong patient demand.
Acoustic wave therapy for tendinopathy, plantar fasciitis, and chronic musculoskeletal conditions. Equipment-based, low consumable cost, strong outcomes.
BPC-157 and TB-500 are the two compounds athletic patients ask for by name, and neither is on the 503A Bulks List, so no pharmacy can lawfully compound them today. ACG builds the adjunct line on sermorelin and FDA-approved agents, and keeps the rest on a tracked watch list. See our Peptide Therapy page for the full compound status table.
HBOT for accelerated recovery, inflammation reduction, and tissue healing. Premium add-on that elevates positioning with the sports recovery patient.
Photobiomodulation for tissue healing, pain reduction, and post-procedure recovery support. Complements every modality on this list.
How ACG Sets Up a
Joint & Musculoskeletal Clinic
From PRP equipment sourcing to Medical Director setup to the brand identity that makes patients choose you over the orthopedic surgeon next door. ACG builds every piece of the infrastructure before your first patient walks in.
Identify whether your market suits joint-focus, sports-recovery focus, or dual positioning, before committing capital.
Entity structure, state licensing, Medical Director introduction and oversight agreement for PRP and regenerative procedures.
Shockwave equipment, PRP kits, and HBOT sourcing at preferred pricing through ACG's pre-vetted vendor network.
The non-surgical alternative positioning that converts the patient who was told surgery was their only option.
Grand opening execution and 60 days of continued ACG advisory, referral development, patient flow, and marketing.
Answers Before
You Open.
Operators looking at joint and regenerative orthopedic clinics want straight answers on PRP and prolotherapy compliance, equipment investment, and the right cash-pay structure. Honest answers below.
If something isn't covered here, that's what the consultation is for. No pressure, no pitch.
View All FAQsWhat services does a joint and musculoskeletal regenerative clinic offer?
What are the state and federal regulations around PRP and regenerative protocols?
Do I need to be a physician to open a regenerative joint clinic?
What equipment investment is required to launch?
How are joint and musculoskeletal patients typically acquired?
Should the clinic accept insurance or operate cash-pay only?
What's the realistic revenue per joint patient?
Where Cellular Products Fit In
Musculoskeletal is the single largest application segment in the stem cell category, which makes a joint clinic the most common entry point for operators adding a cellular service line to an existing practice.
It is also the area the FDA has scrutinized most closely, because orthopedic intended use is exactly where birth-tissue and umbilical-derived products tend to fail the homologous use test and fall into a category requiring premarket approval.
Demand is not the constraint here. A defensible answer to the 361 vs 351 question is. Build that first and the rest of the clinic is straightforward.
The Non-Surgical Alternative
Your Market Is Searching For.
Book a free strategy call. ACG will walk you through the joint and musculoskeletal opportunity in your specific market, competitive landscape, patient demand, and what the compliance and launch process looks like.
Book a Strategy CallFree 30-minute call · No pitch · ACG works with a select number of clients at any given time
Structured to keep you on the right side of the line.
Regenerative health is one of the most heavily scrutinized spaces in medicine. Knowing the rules is not a footnote to what we do. It is the foundation. Here is how we structure every clinic we help launch.
Your Medical Director Directs Care
You own and operate the business. Every clinical, prescribing, and treatment decision is made by an independent, state-licensed Medical Director, structured to respect Corporate Practice of Medicine laws in your state. We connect you to a vetted network; you retain your own provider.
We Know the Regulatory Lines
PRP, peptides, GLP-1 medications, and cellular products each carry their own federal and state rules, and not every product or use is FDA-approved. Some, like exosomes for therapeutic use, are not FDA-approved at all, and we steer you away from them. We help you build a treatment menu on defensible, compliant options and a marketing approach that holds up to FDA, FTC, and state medical board scrutiny.
No Hype. No Guarantees.
We show you real ranges, not fantasy numbers, and we never promise an income or a clinical outcome. What you earn depends on your market, your capital, and your execution. We would rather set honest expectations than sell you a dream.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe, or sell any drug, biologic, device, or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the regulatory compliance of every product, therapy, and claim. See our full regulatory notice below.